Zinc deficiency and clinical practice—validity of zinc preparations

DOI Web Site Web Site PubMed 被引用文献8件 参考文献17件

書誌事項

タイトル別名
  • Zinc Deficiency and Clinical Practice -Validity of Zinc Preparations-

この論文をさがす

抄録

  Zinc is an essential trace element and serves as the active center of approximately 300 enzymes. Therefore, zinc deficiency may be associated with a variety of clinical features such as hypogeusia, hyposmia, growth retardation, dermatitis, alopecia, gonadal hypofunction, abnormal pregnancy, susceptibility to infections, delayed wound healing, impaired glucose tolerance, and increased carcinogenesis. Zinc deficiency was reported to be on the increase in the Nagano Study conducted from 2003 to 2005. Zinc therapy is classified into two categories, zinc-supplementary and -specific treatments. Ordinarily, zinc-supplementary therapy is carried out for the symptoms and diseases caused by zinc deficiency. On the other hand, zinc-specific therapy is applied to obtain copper- and iron-chelating, antifibrotic, and antidiabetic effects. The availability of zinc-specific therapy is now confirmed in humans and animals. Hereafter, the safety of zinc therapy needs to be examined further.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 128 (3), 333-339, 2008

    公益社団法人 日本薬学会

被引用文献 (8)*注記

もっと見る

参考文献 (17)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ